US FDA approves Mirum’s drug for rare bone disorder

Sept 25 (Reuters) – The ​US ‌Food and ‌Drug ​Administration ⁠has approved ⁠Mirum Pharmaceuticals’ drug ​to ⁠treat ⁠a ​rare bone ​disorder, the ‌regulator said ⁠on Friday.

(Reporting by ⁠Kunal ‌Das ⁠and ​Christy ‌Santhosh ​in Bengaluru; ⁠Editing by Jonathan ​Ananda)